Read recent FDA 483 letter on Hospira India - link to FDA website

[Anonymous]

Hospira India 483 letter from FDA website
http://www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm355131.htm

 

[Anonymous]

This 483 is a year and 1/4 old. Rocky Mount had observations that read similarly, and we now know how that turned out in the long run. If you are a demagogue, it won't work. If you are an employee or investor that is just nervous, be patient. The manufacturing and quality group that's been at Hospira for around 2 years now has proven they know how to remediate plants and the CEO has given them a blank check to do it.

 

[Anonymous]

This 483 is a year and 1/4 old. Rocky Mount had observations that read similarly, and we now know how that turned out in the long run. If you are a demagogue, it won't work. If you are an employee or investor that is just nervous, be patient. The manufacturing and quality group that's been at Hospira for around 2 years now has proven they know how to remediate plants and the CEO has given them a blank check to do it.

Don't you know the FDA was pressured by Glaxo to put relentless heat on HSP, which they did !
The plan Is designed to coincide with loss of Precedex in February Like the "perfect storm" these FDA actions/fines in conjunction with Generic Precedex on market will push stock downward
to around $35 by April Glaxo wants to acquire Hsp and will move on it when stock is around $30 range Your threads mean nothing in terms of solutions for current employees
You stupid grunts make me sick !

Hr Guy